TABLE 7.
N (%) | Mean chordoma score | Sig. | |
---|---|---|---|
Number of complications | |||
Mean (SD) | 0.6 (0.9) | .858 Spearman correlation | |
0 | 26 (62%) | 10.5 | |
1 | 6 (14%) | 11.7 | |
2+ | 10 (24%) | 10.4 | |
Severe complicationa | |||
No | 29 (69%) | 10.7 | .910 t-test |
Yes | 13 (31%) | 10.5 | |
Time to death | |||
No | 38 (90%) | 10.3 | .531 Cox regression |
Yes | 4 (10%) | 13.5 | |
Cumulative survival | 78% | ||
Mean survival (mo) | 121 | ||
Mean follow-up (mo) | 60 (42) | ||
Time to recurrence | |||
No | 34 (81%) | 9.8 | .029 Cox regression |
Yes | 8 (19%) | 14.3 | |
Cumulative survival | 59% | ||
Mean survival (mo) | 103 | ||
Mean follow-up (mo) | 50 (39) | ||
Change in KPS at 12 mo | |||
Mean (SD) | 1 (11) | .534 Spearman correlation | |
Worse | 6 (14%) | 10.3 | |
Same | 22 (52%) | 11.3 | |
Better | 14 (33%) | 9.7 | |
Composite outcomeb | .005 Mann–Whitney |
*All significance values are from t-tests, Mann–Whitney, Spearman correlations, and Cox models.
aCerebrospinal fluid leak or major permanent deficit or cranial nerve palsy or reoperation for complication.
bTotal resection and no death/stroke/maj. deficit and no recurrence by 12 mo and KPS 12 > 70.